XML 82 R42.htm IDEA: XBRL DOCUMENT v3.25.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Income Tax Rate from Continuing Operations
Effective Income Tax Rate Reconciliation
202420232022
United States federal statutory rate21.0 %21.0 %21.0 %
United States state and local income taxes, less federal deduction1.1 1.1 2.0 
Foreign income tax at rates other than 21%(4.1)(6.8)(4.1)
Tax related to repatriation of foreign earnings0.3 1.2 (2.4)
United States research and development credits(1.4)(1.2)(1.5)
Intellectual property transfers— (3.3)0.1 
United States federal audit settlement— — (6.1)
Goodwill impairment2.8 — 1.7 
Outside basis difference related to the anticipated sale of the Spinal Implants business(4.9)— — 
Other(0.5)1.8 1.4 
Effective income tax rate14.3 %013.8 %12.1 %
Schedule of Provision for Income Taxes
Earnings Before Income Taxes 
202420232022
United States$523 $701 $407 
International2,969 2,972 2,276 
Total$3,492 $3,673 $2,683 
Components of Income Tax Expense (Benefit)
Current income tax expense (benefit):202420232022
United States federal$490 $236 $(76)
United States state and local90 48 64 
International289 430 279 
Total current income tax expense$869 $714 $267 
Deferred income tax expense (benefit):
United States federal$(462)$(212)$(179)
United States state and local(76)(20)(30)
International168 26 267 
Total deferred income tax expense (benefit)$(370)$(206)$58 
Total income tax expense$499 $508 $325 
Schedule of Difference in Income Tax Effects Comprising Company's Deferred Income Tax Assets and Liabilities
Deferred Income Tax Assets and Liabilities
Deferred income tax assets:20242023
Inventories$551 $521 
Other accrued expenses207 253 
Depreciation and amortization715 918 
State income taxes167 150 
Share-based compensation100 86 
Research and development capitalization408 295 
International interest expense carryforwards52 46 
Net operating loss and credit carryforwards410 385 
Outside basis difference related to the anticipated sale of the Spinal Implants business170 — 
Other310 235 
Total deferred income tax assets$3,090 $2,889 
Less valuation allowances(228)(223)
Net deferred income tax assets$2,862 $2,666 
Deferred income tax liabilities:
Depreciation and amortization$(1,141)$(1,012)
Undistributed earnings(61)(47)
Total deferred income tax liabilities$(1,202)$(1,059)
Net deferred income tax assets$1,660 $1,607 
Reported as:
Noncurrent deferred income tax assets$1,742 $1,670 
Noncurrent liabilities—Other liabilities(82)(63)
Total$1,660 $1,607 
Schedule of Unrecognized Tax Benefits Roll Forward
Uncertain Income Tax Positions
 20242023
Beginning uncertain tax positions$371 $286 
Increases related to current year income tax positions18 102 
Increases related to prior year income tax positions— 10 
Decreases related to prior year income tax positions(4)(33)
Settlements of income tax audits(21)(1)
Statute of limitations expirations and other(3)— 
Foreign currency translation(12)
Ending uncertain tax positions$349 $371 
Reported as:
Noncurrent liabilities—Income taxes$349 $371